aTyr Pharma Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
36,457.00
15,853.00
95,535.00
72,147.00
85,119.00
49,545
Other Current Assets
564.00
656.00
2,415.00
2,621.00
1,866.00
1,258
Total Current Assets
37,021.00
16,509.00
97,950.00
74,768.00
86,985.00
50,803
Net Property, Plant & Equipment
2,505.00
1,925.00
1,793.00
1,421.00
2,280.00
1,853
Total Investments and Advances
-
-
29,814.00
4,002.00
-
-
Long-Term Note Receivable
69.00
69.00
-
-
-
-
Other Assets
260.00
2,210.00
118.00
333.00
90.00
90
Total Assets
39,855.00
20,713.00
129,675.00
80,524.00
89,355.00
52,746
ST Debt & Current Portion LT Debt
935.00
4,634.00
3,366.00
339.00
5,012.00
Accounts Payable
1,055.00
1,433.00
-
-
2,276.00
Other Current Liabilities
3,217.00
4,046.00
8,782.00
8,186.00
3,103.00
Total Current Liabilities
5,207.00
10,113.00
12,148.00
8,525.00
10,391.00
Long-Term Debt
6,158.00
5,142.00
1,776.00
9,198.00
14,719.00
Other Liabilities
1,338.00
780.00
701.00
-
-
Total Liabilities
12,703.00
16,035.00
14,625.00
17,723.00
25,110.00
Common Equity (Total)
68,427.00
90,941.00
115,050.00
62,801.00
64,243.00
Total Shareholders' Equity
24,738.00
4,678.00
115,050.00
62,801.00
64,245.00
Total Equity
27,152.00
4,678.00
115,050.00
62,801.00
64,245.00
Liabilities & Shareholders' Equity
39,855.00
20,713.00
129,675.00
80,524.00
89,355.00
Accumulated Minority Interest
2,414.00
-
-
-
-
Preferred Stock (Carrying Value)
93,165.00
95,619.00
-
-
2.00

About aTyr Pharma

View Profile
Address
3545 John Hopkins Court
San Diego California 92121
United States
Employees -
Website http://www.atyrpharma.com
Updated 07/08/2019
aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of innovative therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics.